Deprescribing medications that may increase the risk of hepatic encephalopathy: A qualitative study of patients with cirrhosis and their doctors

Overview of attention for article published in United European Gastroenterology Journal, February 2021

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (94th percentile)
High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

twitter: 76 X users

Citations

dimensions_citation: 14 Dimensions

Readers on

mendeley: 40 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 101 X posts from 76 X users, with an upper bound of 379,638 followers.

RT @joostphdrenth: Deprescribing medications in cirrhosis 📌Relevant Drugs increase the risk of hepatic encephalopathy 📌How Identify wh…

26 Jan 2022

Reply Repost Favourite

Deprescribing medications that may increase the risk of hepatic encephalopathy: A qualitative study of patients with cirrhosis and their doctors https://t.co/roNtxpdvf1

18 Jan 2022

Reply Repost Favourite

RT @joostphdrenth: Deprescribing medications in cirrhosis 📌Relevant Drugs increase the risk of hepatic encephalopathy 📌How Identify wh…

14 Jan 2022

Reply Repost Favourite

RT @joostphdrenth: Deprescribing medications in cirrhosis 📌Relevant Drugs increase the risk of hepatic encephalopathy 📌How Identify wh…

14 Jan 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 97 additional X posts.